title: Tailoring cyclosporine according to kinetic profiles: does it allow a low-dose therapeutic schedule?
authors.affiliation: Chair of Nephrology, University of Turin, Italy.
authors.forename: G P
authors.initials: GP
authors.lastname: Segoloni
authors.forename: G
authors.initials: G
authors.lastname: Triolo
authors.forename: G
authors.initials: G
authors.lastname: Squiccimarro
authors.forename: L
authors.initials: L
authors.lastname: Colla
authors.forename: E
authors.initials: E
authors.lastname: Turello
authors.forename: G
authors.initials: G
authors.lastname: Aimo
authors.forename: F
authors.initials: F
authors.lastname: Pecchio
authors.forename: A
authors.initials: A
authors.lastname: Vercellone
mesh_terms: D003524:Cyclosporins / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006680:HLA Antigens / Q000032:analysis; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology; D011863:Radioimmunoassay / Q000379:methods
chemical_list: D003524:Cyclosporins; D006680:HLA Antigens